Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

14.53 -2.20 (-13.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLSE
From The Rosen Law Firm, P.A.
Via Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
Via Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
PLSE CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Pulse Biosciences, Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
From Pulse Biosciences, Inc.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.1% to $1.35 during Thursday's regular session. The current volume of 17.5 million shares is 7266.... 
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
51 Biggest Movers From Yesterday
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company... 
Via Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge
US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday. 
Via Benzinga
The Law Offices of Frank R. Cruz Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
What Is Happening With Pulse Biosciences Stock Today?
Pulse Biosciences Inc (NASDAQ: PLSE) shares are tumbling after announcing an update to its recent FDA 510(k) submission to add sebaceous hyperplasia to expand the... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers BioCardia (NASDAQ:BCDA) stock inc... 
Via Benzinga
Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher
US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%. 
Via Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following... 
Via Benzinga
Mid-Morning Market Update: Markets Mostly Higher; Dow Rises 100 Points
US stocks opened mostly higher this morning, with the Dow Jones adding more than 100 points on Tuesday. 
Via Benzinga
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
From Pulse Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.